Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T03:36:28.828Z Has data issue: false hasContentIssue false

Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients

Published online by Cambridge University Press:  27 August 2015

Jennie H. Kwon*
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Kerry M. Bommarito
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Kimberly A. Reske
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Sondra M. Seiler
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Tiffany Hink
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Hilary M. Babcock
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Marin H. Kollef
Affiliation:
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri
Victoria J. Fraser
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
Carey-Ann D. Burnham
Affiliation:
Departments of Pathology & Immunology and Pediatrics, Washington University School of Medicine, St. Louis, Missouri
Erik R. Dubberke
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri
*
Address correspondence to Jennie H. Kwon, DO, Washington University School of Medicine, Division of Infectious Diseases, 6600 S Euclid Ave, Campus Box 8051, St. Louis, MO 63110 (JKwon@dom.wustl.edu).
Rights & Permissions [Opens in a new window]

Abstract

This was a randomized controlled pilot study of Lactobacillus rhamnosus GG versus standard of care to prevent gastrointestinal multidrug-resistant organism colonization in intensive care unit patients. Among 70 subjects, there were no significant differences in acquisition or loss of any multidrug-resistant organisms (P>.05) and no probiotic-associated adverse events.

Infect. Control Hosp. Epidemiol. 2015;36(12):1451–1454

Information

Type
Concise Communications
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 
Figure 0

TABLE 1Pre-enrollment Patient Characteristics

Figure 1

FIGURE 1Flowchart of study protocol.#Submitted <3 samples.*Submitted ≥3 samples.

Figure 2

TABLE 2Colonization Status Throughout Enrollment